Nefize Yalın

ORCID: 0000-0003-4298-5074
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bipolar Disorder and Treatment
  • Electroconvulsive Therapy Studies
  • Schizophrenia research and treatment
  • Functional Brain Connectivity Studies
  • Treatment of Major Depression
  • Child and Adolescent Psychosocial and Emotional Development
  • Advanced Neuroimaging Techniques and Applications
  • Tryptophan and brain disorders
  • Mental Health Research Topics
  • Electrolyte and hormonal disorders
  • Stress Responses and Cortisol
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Neurotransmitter Receptor Influence on Behavior
  • Problem Solving Skills Development
  • Pharmacological Effects and Toxicity Studies
  • Memory and Neural Mechanisms
  • Fetal and Pediatric Neurological Disorders
  • Sexuality, Behavior, and Technology
  • Perfectionism, Procrastination, Anxiety Studies
  • Sex and Gender in Healthcare
  • Genomics and Rare Diseases
  • Adrenal Hormones and Disorders
  • Obsessive-Compulsive Spectrum Disorders
  • Adolescent and Pediatric Healthcare
  • Transcranial Magnetic Stimulation Studies

King's College London
2017-2025

National Institute of Mental Health
2024

National Institutes of Health
2024

South London and Maudsley NHS Foundation Trust
2021-2023

National Health Service
2023

Maudsley Hospital
2023

Bethlem Royal Hospital
2022

Dokuz Eylül University
2013-2019

University of North Carolina at Chapel Hill
2014

Derrek P. Hibar Lars T. Westlye Nhat Trung Doan Neda Jahanshad J. Cheung and 95 more Christopher R. K. Ching Amelia Versace Amy C. Bilderbeck Anne Uhlmann Benson Mwangi Bernd Krämer Bronwyn J. Overs Cecilie B. Hartberg Christoph Abé Danai Dima Dominik Grotegerd Emma Sprooten Erlend Bøen Esther Jiménez Fleur M. Howells Giuseppe Delvecchio Henk Temmingh Jonathan Starke Jorge Almeida José Manuel Goikolea Josselin Houenou Lauren M. Beard Lisa Rauer Lucija Abramovic M. Bonnin Maria Francesca Ponteduro Maria Keil Maria M. Rive Nailin Yao Nefize Yalın Pablo Najt Pedro G. P. Rosa Ronny Redlich Sarah Trost Saskia P. Hagenaars Scott C. Fears Sílvia Alonso-Lana Theo G.M. van Erp Thomas E. Nickson Tiffany M. Chaim‐Avancini Timothy B. Meier Torbjørn Elvsåshagen Unn K. Haukvik W H Lee Aart H. Schene Adrian J. Lloyd Allan H. Young Allison C. Nugent Anders M. Dale Andrea Pfennig Andrew M. McIntosh Beny Lafer Bernhard T. Baune Carl Johan Ekman Carlos A. Zarate Carrie E. Bearden Chantal Henry Christian Simhandl Colm McDonald Corin Bourne Dan J. Stein Daniel H. Wolf Dara M. Cannon David C. Glahn Dick J. Veltman Edith Pomarol‐Clotet Eduard Vieta Erick J. Canales‐Rodríguez Fabiano G. Nery Fábio Duran Geraldo F. Busatto Gloria Roberts Godfrey D. Pearlson Guy M. Goodwin Harald Kugel Heather C. Whalley Henricus G. Ruhé Jair C. Soares Janice M. Fullerton Janusz Rybakowski Jonathan Savitz Kalil T Chaim Mar Fatjó‐Vilas Márcio Gerhardt Soeiro‐de‐Souza Marco P. Boks Marcus V. Zanetti Maria Concepción García Otaduy Maria Schaufelberger Martin Alda Martin Ingvar Mary L. Phillips Matthew J. Kempton Michael J. Bauer Mikael Landén Natalia Lawrence

Despite decades of research, the pathophysiology bipolar disorder (BD) is still not well understood. Structural brain differences have been associated with BD, but results from neuroimaging studies inconsistent. To address this, we performed largest study to date cortical gray matter thickness and surface area measures magnetic resonance imaging scans 6503 individuals including 1837 unrelated adults BD 2582 healthy controls for group while also examining effects commonly prescribed...

10.1038/mp.2017.73 article EN cc-by-nc-nd Molecular Psychiatry 2017-05-02

Cognitive remediation therapy (CRT) may benefit people with bipolar disorder type I and II for whom cognitive impairment is a major contributor to disability. Extensive research has demonstrated CRT improve cognition psychosocial functioning in different diagnoses, but randomised trials of evidenced programmes are lacking disorders. The Remediation Bipolar (CRiB) study aimed determine whether an established programme feasible acceptable disorders.This proof-of-concept, single-blind trial...

10.1111/bdi.12968 article EN cc-by Bipolar Disorders 2020-06-25

Background Several lines of evidence suggest that bipolar disorder (BD) is associated with white matter (WM) pathology. Investigation unaffected first-degree relatives BD patients may help to distinguish structural biomarkers genetic risk without the confounding effects burden illness, medication or clinical state. In present study, we applied tract-based spatial statistics study WM changes in BD, siblings and controls. Method A total 27 euthymic type I, 20 29 healthy controls who did not...

10.1017/s0033291716000180 article EN Psychological Medicine 2016-03-07

Objectives The current study aimed to assess both response inhibition ( RI ) and interference control IC in euthymic patients with bipolar disorder BD ‐Ps) as well asymptomatic first‐degree relatives ‐Rs) healthy controls HC s) order evaluate trait‐as opposed illness‐associated features of these components. Methods ‐Ps (n = 35) who had been the state for at least six months, ‐Rs 30), s 33) completed a Stop‐Signal Task SST Stroop , respectively. Groups were compared on stop‐signal reaction...

10.1111/bdi.12335 article EN Bipolar Disorders 2015-09-29

Abstract: Depression accounts for the predominant burden associated with bipolar disorder. The identification and management of depression are challenging, since differs from unipolar depression, responding poorly to traditional antidepressants, which may also induce a switch hypomania/mania, mixed states and/or cause rapid cycling. Current treatment options limited guidelines vary greatly in their recommendations, reflecting gaps inconsistencies current evidence base. Moreover, some...

10.2147/ndt.s245166 article EN cc-by-nc Neuropsychiatric Disease and Treatment 2020-06-01

So far, few studies have investigated cortical thickness (CT) and surface area (SA) measures in bipolar disorder type I (BDI) comparison to a high genetic risk group such as first-degree relatives (FR). This study aimed examine CT SA differences between BDI, FR healthy controls (HC). 3D T1 magnetic resonance images were acquired from 27 euthymic BDI patients, 24 unaffected 29 HC. obtained with FreeSurfer version 5.3.0. Generalized estimating equations used compare groups. Group comparisons...

10.1016/j.nicl.2019.101695 article EN cc-by NeuroImage Clinical 2019-01-01

Introduction: This study aimed to assess the reliability and validity of Turkish version The DSM-5 Level 2 Depression Scale. Method: group included a case that consisted clinical sample diagnosed with depressive disorder continued treatment in child adolescent psychiatry unit community sample. was carried out 218 children 160 parents. Child Inventory Strengths Difficulties Questionnaire- Parent Form were used along Scale for assessment. Results: In analyses, Cronbach alpha internal...

10.5455/jcbpr.253026 article EN Journal of Cognitive-Behavioral Psychotherapy and Research 2017-01-01
Coming Soon ...